Pharma and Biotech
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 31-Oct-2024 | 09:57 | RNS |
Total Voting Rights | 31-Oct-2024 | 07:00 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 30-Oct-2024 | 11:08 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 29-Oct-2024 | 09:54 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 28-Oct-2024 | 09:50 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 25-Oct-2024 | 10:34 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 24-Oct-2024 | 11:21 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 23-Oct-2024 | 10:33 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 22-Oct-2024 | 11:43 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 22-Oct-2024 | 10:07 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 21-Oct-2024 | 11:02 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 18-Oct-2024 | 10:21 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 17-Oct-2024 | 09:59 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 11-Oct-2024 | 10:51 | RNS |
Form 8.5 (EPT/RI) - Benchmark Holdings plc | 10-Oct-2024 | 10:13 | RNS |
Currency | UK Pounds |
Share Price | 37.45p |
Change Today | 1.00p |
% Change | 2.74 % |
52 Week High | 48.00 |
52 Week Low | 34.00 |
Volume | 0 |
Shares Issued | 739.79m |
Market Cap | £277.05m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research